新冠康复学生运动员心肌炎的心脏磁共振评估
该病例系列在威斯康星大学连续纳入145名新冠康复的竞技学生运动员,于新冠阳性后中位15天行钆增强心脏磁共振,按更新版Lake Louise标准判读。仅2例(1.4%,95%CI 0.4%-4.9%)符合心肌炎表现,提示在该无症状或轻中度症状人群中筛查心肌炎的效用存疑。
要点
- 新冠康复学生运动员中心肌炎MRI检出率低,为1.4%。
- 多数患者急性期症状轻微、中度或无症状,无人住院。
- 心脏磁共振作为该人群心肌炎筛查工具的效用存疑。
核心结论
- 在新冠康复且无或仅有轻中度症状的学生运动员中,基于MRI的心肌炎患病率低(1.4%),心脏磁共振作为筛查工具的效用存疑。
研究设计与样本
- 本研究为病例系列,在威斯康星大学通过电子健康记录检索连续纳入2020年1月1日至2020年11月29日期间新冠康复并接受钆增强心脏磁共振的竞技学生运动员。
- 共纳入145名竞技学生运动员(108名男性,37名女性;平均年龄20岁,范围17-23岁),新冠感染经逆转录聚合酶链反应检测确认。
- MRI结果由2名心脏影像经验丰富的放射科医生依据更新版Lake Louise标准审阅,同时获取心肌损伤与炎症血清标志物、心电图、经胸超声心动图及相关临床数据。
主要发现
- 急性感染期间多数患者症状轻微(71例,49.0%)、中度(40例,27.6%)或无症状(24例,16.6%),10例(6.9%)症状未明确或未记录,无人需要住院。
- 心脏磁共振在新冠检测阳性后中位15天(范围11-194天)进行。
- 2例患者MRI表现符合心肌炎(1.4% [95%CI,0.4%-4.9%])。
- 其中1例在多节段出现显著非缺血性晚期钆增强和T2加权信号异常,伴血清肌钙蛋白-I水平异常;另1例有1厘米非缺血性轻度晚期钆增强和轻度T2加权信号异常,实验室检查正常。
临床怎么用
- 对于新冠康复后无或仅有轻中度症状的竞技学生运动员,不应常规以心脏磁共振作为心肌炎筛查工具。
局限性
- 本研究为单中心病例系列,样本为连续接受心脏磁共振的竞技学生运动员,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The utility of cardiac magnetic resonance imaging (MRI) as a screening tool for myocarditis in competitive student athletes returning to training after recovering from coronavirus disease 2019 (COVID-19) infection is unknown. OBJECTIVE: To describe the prevalence and severity of cardiac MRI findings of myocarditis in a population of competitive student athletes recovering from COVID-19. DESIGN, SETTING, AND PARTICIPANTS: In this case series, an electronic health record search was performed at our institution (University of Wisconsin) to identify all competitive athletes (a consecutive sample) recovering from COVID-19, who underwent gadolinium-enhanced cardiac MRI between January 1, 2020, and November 29, 2020. The MRI findings were reviewed by 2 radiologists experienced in cardiac imaging, using the updated Lake Louise criteria. Serum markers of myocardial injury and inflammation (troponin-I, B-type natriuretic peptide, C-reactive protein, and erythrocyte sedimentation rate), an electrocardiogram, transthoracic echocardiography, and relevant clinical data were obtained. EXPOSURES: COVID-19 infection, confirmed using reverse transcription-polymerase chain reaction testing. MAIN OUTCOMES AND MEASURES: Prevalence and severity of MRI findings consistent with myocarditis among young competitive athletes recovering from COVID-19. RESULTS: A total of 145 competitive student athletes (108 male and 37 female individuals; mean age, 20 years; range, 17-23 years) recovering from COVID-19 were included. Most patients had mild (71 [49.0%]) or moderate (40 [27.6%]) symptoms during the acute infection or were asymptomatic (24 [16.6%]). Symptoms were not specified or documented in 10 patients (6.9%). No patients required hospitalization. Cardiac MRIs were performed a median of 15 days (range, 11-194 days) after patients tested positive for COVID-19. Two patients had MRI findings consistent with myocarditis (1.4% [95% CI, 0.4%-4.9%]). Of these, 1 patient had marked nonischemic late gadolinium enhancement and T2-weighted signal abnormalities over multiple segments, along with an abnormal serum troponin-I level; the second patient had 1-cm nonischemic mild late gadolinium enhancement and mild T2-weighted signal abnormalities, with normal laboratory values. CONCLUSIONS AND RELEVANCE: In this case series study, based on MRI findings, there was a low prevalence of myocarditis (1.4%) among student athletes recovering from COVID-19 with no or mild to moderate symptoms. Thus, the utility of cardiac MRI as a screening tool for myocarditis in this patient population is questionable.
引用
- Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021. PMID: 33443537. doi:10.1001/jamacardio.2020.7444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。